menu
    • menu

    Company profile for OncoBeta

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OncoBeta® GmbH with its headquarters located at the Garching Technology and Founders Center GATE near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies utilizing epidermal radioisotope applications. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization ...
    OncoBeta® GmbH with its headquarters located at the Garching Technology and Founders Center GATE near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies utilizing epidermal radioisotope applications. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers. Since then, OncoBeta® has successfully perfected the customized application and device management system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OncoBetaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Schleißheimer Str. 91 85748 Garching near Munich
    Telephone
    Telephone
    +49 (89) 32667330
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncobeta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncobeta-gmbh/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OncoBeta Posts 12-Month Phase IV Data in Skin Cancer
    OncoBeta Posts 12-Month Phase IV Data in Skin Cancer

    13 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncobeta-reports-12-month-results-from-international-phase-iv-study-for-non-melanoma-skin-cancer-302529239.html

    PR NEWSWIRE
    13 Aug 2025
    Share Share
    OncoBeta Expands Rhenium-SCT In Italy For Skin Cancer
    OncoBeta Expands Rhenium-SCT In Italy For Skin Cancer

    02 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncobeta-announces-the-expansion-of-rhenium-sct-for-non-melanoma-skin-cancer-patients-in-italy-302213212.html

    PR NEWSWIRE
    02 Aug 2024
    Share Share
    OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste)
    OncoBeta Announces Approval and ARTG Listing of Rhenium-SCT (Rhenium-188 paste)

    18 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/oncobeta-announces-approval-and-artg-listing-of-rhenium-sct-rhenium-188-paste-in-australia-for-the-treatment-of-skin-cancer-lesions-and-skin-tumors-301196262.html

    PRNEWSWIRE
    18 Dec 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search